GlassScriptPhysician profile
Jeff X Zhao
NPI 1598828758
$32,156.36
in general payments reported to CMS, 2019-2025
40 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $472 · 2021: $1,142 · 2022: $926 · 2023: $6,119 · 2024: $9,723 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $6,208 · Food and Beverage: $5,906 · Gift: $82.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,520.54 |
| Travel and Lodging | $6,208.26 |
| Food and Beverage | $5,906.44 |
| Gift | $82.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $20,377.63 | 2021-2025 | Inset System |
| Stryker Corporation | $4,571.51 | 2019-2025 | Blueprint Patient Specific Instrumentation, Gamma, Mako |
| Fx Shoulder Solutions, INC | $2,712.62 | 2019-2025 | |
| Medical Device Business Services, INC. | $740.50 | 2023 | Bristow Latarjet |
| Wright Medical Technology, INC. | $522.67 | 2019 | |
| Linvatec Corporation | $489.13 | 2020-2025 | Biobrace 23mm, Linvatec Arthroscopy, Hall Power |
| Depuy Synthes Sales INC. | $398.49 | 2020-2024 | Na, Orthovisc, Monovisc |
| Bone Support INC. | $307.85 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Smith+Nephew, INC. | $247.76 | 2021-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $172.99 | 2021-2025 | Durolane, Durolane |
| Orthofix Medical, INC. | $158.81 | 2022-2025 | Physio-Stim |
| Pylant Medical | $143.26 | 2020-2025 | |
| Medacta USA, INC. | $135.94 | 2023 | Reverse Shoulder |
| Heron Therapeutics, INC. | $132.13 | 2021-2023 | Zynrelef |
| Uoc USA INC | $108.42 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $100.38 | 2019 | |
| Encore Medical, LP | $92.69 | 2024 | Djo Surgical |
| Vertex Pharmaceuticals Incorporated | $80.14 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $73.44 | 2020-2023 | Exparel, Zilretta, Iovera |
| Innovation Technologies INC | $66.29 | 2022-2025 | Irrisept |
| Organogenesis INC. | $44.67 | 2021 | |
| Kerecis Limited | $44.60 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Next Science LLC | $41.08 | 2024 | Blastx, Surgx, Xperience |
| Siemens Medical Solutions USA, INC. | $37.63 | 2024 | Magnetom Free.Max |
| Ethicon US, LLC | $36.69 | 2024 | Stratafix |
| Amgen INC. | $35.43 | 2019 | |
| Electronic Waveform Lab, INC. | $34.24 | 2024-2025 | |
| Axogen | $29.35 | 2025 | |
| Biotissue Holdings INC. | $26.56 | 2022 | |
| Cardiovascular Systems INC. | $24.78 | 2022 | |
| Davol INC. | $23.57 | 2025 | Arista |
| Abbott Laboratories | $23.18 | 2021 | |
| Nalu Medical, INC. | $20.24 | 2025 | Nalu Neurostimulation System |
| Biocomposites INC | $17.91 | 2019 | |
| Fidia Pharma USA INC. | $16.31 | 2024 | Hymovis, Triluron, Hyalgan |
| Cpm Medical Consultants, LLC | $16.01 | 2020 | |
| Convatec INC. | $15.39 | 2020 | |
| Trice Medical, INC. | $14.79 | 2019 | |
| Arthrosurface Incorporated | $13.28 | 2019 | |
| Kinex Medical Company LLC | $8.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Zhao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.